LS2 Intersection Cardiovascular Biology


Cardiac vascular diseases (CVDs) are and will remain the first cause of mortality in the world accounting for 30% deaths worldwide. 15 million people died in 2015 from ischemic heart diseases and stroke. This number will increase to reach 23.3 million by 2030. CVDs are defined by the world health organization as “a group of disorders of the heart and blood vessels”, suggesting that strong interactions exist between the cardiac and vascular fields.

That is why the working group of cardiovascular biology was founded by clinicians and researchers working in cardiology and in the vascular domain. This interaction is the specificity of our group, which is also supported by the Swiss Society of Cardiology.

At origin, the purpose of the working group of cardiovascular biology is:

  • To provide an open forum for cardio-vascular scientists (basic researchers and clinicians)
  • To promote and enhance education for young colleagues
  • To intensify collaborations within Switzerland
  • To provide an annual meeting platform for network programs

If certain aspects of our research are specific to the heart and the vessels, others are common with researchers working on stem cells, regenerative medicine, autophagy, and heart and vessel metabolism. That is why people who are not working in the cardiovascular field can also benefit from the knowledge acquired in the cardiovascular domain.

Therefore, LS2 and Swiss Society of Cardiology founded Cardiovascular Biology Intersection in November 2017 to aid interactions and networking among research groups from different fields.

Section Board

President

Sarah Longnus
University of Bern

Vice-President

Lucio Barile
Università della Svizzera italiana

Past-President

Marie-Luce Bochaton-Piallat
University of Geneva

Board Member

Jan Kucera
University of Bern

Board Member

Anna Jazwinska
University of Fribourg

Board Member

Nathalie Rosenblatt-Velin
CHUV Lausanne

Board Member

Andrea Banfi
University of Basel

Board Member and delegate for Swiss Society of Cardiology (SGK)

Giovanni G. Camici
University of Zurich

Board Member

Gabriela Kania
University Hospital Zurich

Board Member

Marie-Noelle Giraud
University of Fribourg

Board Member

Carolina Balbi
University of Zurich

News and Events:

Attend our Symposium at LS2 Annual Meeting 2026

Our Mini-Symposium at LS2 Annual Meeting 2026 will be chaired by Marie-Noelle Giraud (University of Fribourg) and Giovanni G. Camici (University of Zurich): “Extracellular Vesicles in Cardiovascular Therapeutics”

Speaker: Philippe Menasche (Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, Paris, France): "Extracellular vesicles for the treatment of heart failure: a translational experience"

Register by 11.01.2026

The Meeting will take place on 11 & 12 February 2026 at Campus Irchel of the University of Zurich.

LS2 Cardiovascular Research Meeting 2026

When: Tuesday 13 January – Wednesday 14 January 2026
Where: UniS – University of Bern, Bern, Switzerland

Are you pushing the boundaries in cardiovascular research? This is your chance to connect, share, and inspire.

Why attend:

  • Hear from leading experts via plenary talks and lectures
  • Present your own work
  • Network with fellow researchers, clinicians, and industry partners
  • Enjoy a dinner event for informal discussions and collaboration
  • Take in the latest in cardiovascular science in one of Switzerland’s academic hubs

Registration and abstract submission has now closed.

Postdoctoral Position in Vascular Research, Geneva

The selected candidate will join the laboratory of Prof. Marie‐Luce Bochaton‐Piallat in the Department of Pathology and Immunology of the Faculty of Medicine, University of Geneva, Switzerland.

Affiliations

Swiss Society of Cardiology